Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
82,773,190
-
Total 13F shares
-
30,385,119
-
Share change
-
+2,391,982
-
Total reported value
-
$934,032,943
-
Put/Call ratio
-
154%
-
Price per share
-
$30.73
-
Number of holders
-
146
-
Value change
-
+$80,818,257
-
Number of buys
-
85
-
Number of sells
-
40
Institutional Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q4 2017
As of 31 Dec 2017,
Editas Medicine, Inc. - Common Stock (EDIT) was held by
146 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,385,119 shares.
The largest 10 holders included
FMR LLC, Vanguard Group Inc, BlackRock Inc., STATE STREET CORP, Capital World Investors, Viking Global Investors LP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Flagship Pioneering Inc., ARK Investment Management LLC, and TRV GP III, LLC.
This page lists
146
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.